The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer-Reference-Cited by-同舟云学术

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer

Published:2017-06-10 Issue:7 Volume:6 Page:1614-1626
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Imai Daisuke¹,Yoshizumi Tomoharu¹,Okano Shinji¹²,Uchiyama Hideaki¹,Ikegami Toru¹,Harimoto Norifumi¹,Itoh Shinji¹,Soejima Yuji¹,Aishima Shinichi³,Oda Yoshinao⁴,Maehara Yoshihiko¹

Affiliation:

1. Department of Surgery and Science; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan

2. Department of General surgery; Digestive Disease and Surgery institute; Cleveland Clinic; Cleveland USA

3. Department of Pathology and Microbiology; Saga Medical School; Faculty of Medicine; Saga University; Saga Japan

4. Department of Anatomic Pathology; Pathological sciences; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1087/fullpdf

Reference47 articles.

1. (Center for Cancer Control and Information Services, National Cancer Center, 2013) http://ganjoho.jp/professional/statistics/statistics.html

2. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

3. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

4. Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma;Royal;J. Immunother.,2010

5. Human macrophage metalloelastase worsens the prognosis of pancreatic cancer;Balaz;Ann. Surg.,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics;PLOS ONE;2024-07-02

2. Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells;International Journal of Molecular Sciences;2024-03-11

3. Research Progress of MHC in Tumors;Advances in Clinical Medicine;2024

4. HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events;Journal of Cancer Research and Clinical Oncology;2023-01-20

5. Prognostic significance of PD-L1 expression in pancreatic cancer: evidence from an updated meta-analysis;Polish Journal of Pathology;2023